A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19  HB-adMSCs  56  Dose: five IV infusions  Phase 2  USA  60